Pathogenesis of AIDS-related dilated cardiomyopathy

AIDS Reviews

Volumn 3, Issue 1, 2001, Pages 36-43

  Sundstrom, J B ^a   Ansari, A A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Cocaine; HIV; Metalloproteinase

Indexed keywords

ANTIRETROVIRUS AGENT; COCAINE; ILLICIT DRUG; METALLOPROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; CARDIOTOXICITY; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG MECHANISM; GENETIC HETEROGENEITY; HEART DILATATION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; LEUKOCYTE; MYOCARDITIS; NUTRITIONAL DISORDER; OPPORTUNISTIC INFECTION; PATHOGENESIS; REVIEW; RISK FACTOR; TISSUE INTERACTION; VASCULAR ENDOTHELIUM; VIRUS CELL INTERACTION;

EID: 0035027392     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms
2. The molecular and cellular pathophysiology of heart failure
3. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline crosslinks
4. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
5. Matrix metalloproteinases and cardiovascular disease
6. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome
7. Cardiac involvement in acquired immunodeficiency syndrome - A review to push action. The Committee for the Study of Cardiac Involvement in AIDS
8. Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: Role of proinflammatory cytokines and chemokines in viral expression modulation
9. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells
10. The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis
11. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression
12. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines
13. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis
14. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes
15. Effects of extracellular human immunodeficiency virus type 1 Vpr protein in primary rat cortical cell cultures
16. Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium
17. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases
18. The molecular mechanism of cardiac hypertrophy and failure
19. Signaling pathways in cardiac myocyte hypertrophy
20. Future perspectives and potential implications of cardiac myocyte apoptosis
21. Apoptosis and cardiomyopathy
22. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
23. Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target
24. HIV-1 infection of human brain-derived microvascular endothelial cells in vitro
25. Human endothelial cells isolated from the hepatic sinusoids and the umbilical vein display a different permissiveness for HIV1
26. In vitro tropism of various HIV/SIV strains for different primary endothelial cells and its potential significance in vivo
27. Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector
28. Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: Detection by multiplex, nested, polymerase chain reaction in individually microdissected cells from right ventricular endomyocardial biopsy tissue
29. Infection of the heart by the human immunodeficiency virus
30. The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy
31. Viral infection and the pathogenesis of dilated cardiomyopathy
32. Cocaine injection and coxsackievirus B3 infection increase heart disease during murine AIDS
33. In situ detection of human cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy
34. Cytomegalovirus-induced immunosuppression
35. Coxsackievirus B3 infection leads to cell death of cardiac myocytes
36. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: An approach to the study of enteroviral persistence in cardiac myocytes
37. Autoimmunity in myocarditis: Relevance of animal models
38. Roles of T cells in coxsackievirus B-induced disease
39. Enteroviruses and myocarditis: Viral pathogenesis through replication, cytokine induction, and immunopathogenicity
40. Review of microbial infections and the immune response to cardiac antigens
41. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy
42. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue
43. Nutrients and HIV: Part two - Vitamins A and E, zinc, B-vitamins, and magnesium
44. Nutrients and HIV: Part one - Beta carotene and selenium
45. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS)
46. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)infection
47. Dilated cardiomyopathy and selenium deficiency in AIDS. A propos of a case
48. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome
49. Is nonobstructive cardiomyopathy in AIDS a selenium deficiency-related disease?
50. Regulation of cardiac sarcolemmal Na+/H+ exchanger activity: Potential pathophysiological significance of endogenous mediators and oxidant stress
51. Role of oxidative stress in cardiovascular diseases
52. Tumor necrosis factor in the heart
53. Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro
54. Selenium and interleukins in persons infected with human immunodeficiency virus type 1
55. Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency
56. Glutathione peroxidase protects mice from viral-induced myocarditis
57. Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells
58. Zidovudine-induced experimental myopathy: Dual mechanism of mitochondrial damage
59. Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat
60. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine
61. Cardiovascular hypertrophy and increased vascular contractile responsiveness following repeated cocaine administration in rabbits
62. Molecular characteristics of cocaine-induced cardiomyopathy in rats
63. Catecholamines in cardiac hypertrophy
64. Cardiac complications of cocaine abuse
65. Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases
66. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas
67. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy
68. Growth hormone and the heart
69. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts
70. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro
71. Cardiotrophin-1: A multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways
72. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp 130 signaling complex
73. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes
74. Effect of interleukin-1 beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture
75. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes
76. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes
77. Tumor necrosis factor in myocardial hypertrophy and ischaemia - An anti-apoptotic perspective
78. Angiotensin II, adhesion, and cardiac fibrosis
79. Role of the renin-angiotensin system in cardiac hypertrophy
80. Endothelin-induced cardiac myocyte hypertrophy: Role for focal adhesion kinase
81. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy?